This study will evaluate the cost-effectiveness of an organizational-level intervention in a randomized controlled trial involving 900 treated hypertensive African American patients in the Milwaukee and Chicago areas. The study will involve 36 community pharmacies (18 intervention, 18 control) owned by a pharmacy corporation that operates over 2,000 pharmacies nationwide. The intervention will include: a) redefinition of pharmacist and pharmacy technician roles, b) implementation of a pharmacy-based “refill clinic” and tools for enhanced monitoring and collaboration with patients and physicians, and c) special training/certification of pharmacy personnel in blood pressure measurement, collaborative skills, and cultural competency.

Condition	Intervention
hypertension in African Ammericans	Behavior: educational

Further Study Details: 

Primary Outcomes: the cost-effectiveness of an organizational-level intervention in treating hypertensive African Americans in Milwaukee and Chicago
Secondary Outcomes: how did the intervention affect the process of care (including pharmacists behavior, patient-reported barriers, prescribed regimens, patient adherence)
Expected Total Enrollment:  900

Ages Eligible for Study:  18 Years and above,  Genders Eligible for Study:  Both

Criteria

Inclusion Criteria:

• african american
• 18 y/o or older
• obtain all prescribed drugs at the study pharmacy

Exclusion Criteria:

• history of organ transplant
• kidney dialysis
• terminal illness

Please refer to this study by ClinicalTrials.gov identifier  NCT00205153

Bonnie L Svarstad, PhD      608-265-2128    blsvarstad@pharmacy.wisc.edu

Wisconsin
      University of Wisconsin, Madison,  Wisconsin,  53792,  United States

Study chairs or principal investigators

Bonnie L Svarstad, PhD,  Principal Investigator,  University of Wisconsin   

Study ID Numbers:  M-2000-0284; NIH R01 HL78580
Last Updated:  September 19, 2005
Record first received:  September 13, 2005
ClinicalTrials.gov Identifier:  NCT00205153
Health Authority: United States: Institutional Review Board
ClinicalTrials.gov processed this record on 2005-09-20